Company Filing History:
2 out of 53 
1 out of 1,310 
1 out of 318 
Years Active: 1988-2008
Title: Tetsuo Noda: Innovator in Arteriosclerosis Treatment
Introduction
Tetsuo Noda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of arteriosclerosis. With a total of 4 patents, Noda's work focuses on innovative methods to combat this serious health condition.
Latest Patents
Noda's latest patents include a method for treating arteriosclerosis, which involves a scavenger receptor A expression down-regulator. This invention presents a drug for preventing or treating arteriosclerosis that contains, as the active ingredient, a C-terminal globular domain of adiponectin, adiponectin itself, or a gene encoding the domain or adiponectin. The invention aims to provide a preventive or therapeutic agent capable of directly preventing intimal thickening, a key feature of arteriosclerosis. This effect is achieved by reducing the expression level of scavenger receptor A in arterial walls, thereby preventing lipid buildup in macrophages.
Another notable patent involves non-human animals deficient in the function of a uridine phosphorylase gene on a chromosome, along with their offspring. These animals are instrumental in elucidating pathologic functions and activities of nucleic acid dysbolism, and they also help predict the utility of pyridine nucleoside antimetabolites in humans. This research is valuable for experimental purposes.
Career Highlights
Throughout his career, Tetsuo Noda has worked with notable organizations such as Aderans Company Limited and the Japan Science and Technology Agency. His contributions to these institutions have furthered research and development in medical treatments.
Collaborations
Noda has collaborated with esteemed colleagues, including Hiroshi Kakiuchi and Setsuo Fukuhara. Their joint efforts have enhanced the impact of his research and innovations.
Conclusion
Tetsuo Noda's work in the field of arteriosclerosis treatment showcases his dedication to medical innovation. His patents reflect a commitment to improving health outcomes and advancing scientific knowledge.